FiercePharma @FiercePharma · 27 Aug 2026
An inexperienced RevMed is now responsible for launching the most hotly anticipated cancer drug in years. https://t.co/vfyPNDK7uH
3 686Views
11Likes
3Reposts
1Replies
0Quotes
3Bookmarks
Is that a lot?
0.87×vs this author's median4 231 views is typical
17Percentile for this authorof 6 recent posts
0.60×vs 100K–1M median6 116 views is typical
3.66%Reachviews ÷ followers
0.41%Engagement rateof viewers reacted